Table 16.
Selected Childhood Brain and Central Nervous System Tumor, Average Annual Age-Adjusted and Age-Specific Incidence Rates† by Major Histology Groupings, Histology and Age at Diagnosis, CBTRUS Statistical Report: NPCR and SEER, 2005–2009
| Age At Diagnosis |
Age at Diagnosis |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0-4 |
5-9 |
10-14 |
15-19 |
0-19‡ |
0-14‡ |
|||||||
| Rate | 95% CI | Rate | 95% CI | Rate | 95% CI | Rate | 95% CI | Rate | 95% CI | Rate | 95% CI | |
| Tumors of Neuroepithelial Tissue | 4.50 | (4.37-4.63) | 3.68 | (3.56-3.81) | 3.17 | (3.06-3.28) | 2.74 | (2.64-2.84) | 3.51 | (3.45-3.57) | 3.77 | (3.70-3.84) |
| Pilocytic astrocytoma | 0.87 | (0.82-0.93) | 0.89 | (0.83-0.95) | 0.86 | (0.80-0.92) | 0.59 | (0.55-0.64) | 0.80 | (0.78-0.83) | 0.87 | (0.84-0.91) |
| Diffuse astrocytoma | 0.33 | (0.29-0.37) | 0.22 | (0.19-0.25) | 0.26 | (0.23-0.30) | 0.26 | (0.23-0.29) | 0.27 | (0.25-0.28) | 0.27 | (0.25-0.29) |
| Anaplastic astrocytoma | 0.05 | (0.04-0.07) | 0.08 | (0.07-0.10) | 0.09 | (0.07-0.11) | 0.09 | (0.08-0.11) | 0.08 | (0.07-0.09) | 0.08 | (0.07-0.09) |
| Unique astrocytoma variants | 0.06 | (0.05-0.08) | 0.10 | (0.08-0.12) | 0.14 | (0.11-0.16) | 0.13 | (0.11-0.16) | 0.11 | (0.10-0.12) | 0.10 | (0.09-0.11) |
| Glioblastoma | 0.09 | (0.07-0.11) | 0.14 | (0.12-0.17) | 0.16 | (0.14-0.19) | 0.17 | (0.14-0.19) | 0.14 | (0.13-0.15) | 0.13 | (0.12-0.15) |
| Oligodendroglioma | 0.03 | (0.02-0.04) | 0.04 | (0.03-0.05) | 0.06 | (0.04-0.08) | 0.11 | (0.09-0.13) | 0.06 | (0.05-0.07) | 0.04 | (0.04-0.05) |
| Anaplastic oligodendroglioma | – | – | – | – | – | – | 0.02 | (0.02-0.04) | 0.01 | (0.01-0.02) | 0.01 | (0.01-0.01) |
| Oligoastrocytic tumors | 0.03 | (0.02-0.04) | 0.03 | (0.02-0.04) | 0.03 | (0.02-0.05) | 0.05 | (0.04-0.07) | 0.03 | (0.03-0.04) | 0.03 | (0.02-0.04) |
| Ependymal tumors | 0.40 | (0.36-0.44) | 0.23 | (0.20-0.26) | 0.21 | (0.19-0.24) | 0.26 | (0.23-0.30) | 0.27 | (0.26-0.29) | 0.28 | (0.26-0.30) |
| Glioma malignant, NOS | 0.86 | (0.81-0.92) | 0.81 | (0.75-0.87) | 0.43 | (0.39-0.47) | 0.24 | (0.22-0.28) | 0.58 | (0.56-0.61) | 0.70 | (0.67-0.73) |
| Choroid plexus tumors | 0.26 | (0.23-0.29) | 0.04 | (0.03-0.06) | 0.04 | (0.03-0.05) | 0.05 | (0.04-0.06) | 0.10 | (0.09-0.11) | 0.11 | (0.10-0.12) |
| Other neuroepithelial tumors | – | – | – | – | – | – | – | – | 0.01 | (0.01-0.01) | 0.01 | (0.01-0.01) |
| Neuronal and mixed neuronal-glial tumors | 0.24 | (0.21-0.28) | 0.30 | (0.27-0.34) | 0.43 | (0.39-0.48) | 0.46 | (0.42-0.51) | 0.36 | (0.34-0.38) | 0.33 | (0.31-0.35) |
| Tumors of the pineal region | 0.05 | (0.04-0.07) | 0.04 | (0.03-0.05) | 0.03 | (0.02-0.05) | 0.04 | (0.03-0.05) | 0.04 | (0.04-0.05) | 0.04 | (0.03-0.05) |
| Embryonal tumors | 1.21 | (1.15-1.28) | 0.76 | (0.70-0.81) | 0.39 | (0.35-0.43) | 0.25 | (0.22-0.28) | 0.65 | (0.62-0.67) | 0.78 | (0.75-0.81) |
| Tumors of Cranial and Spinal Nerves | 0.27 | (0.24-0.30) | 0.21 | (0.18-0.24) | 0.26 | (0.22-0.29) | 0.35 | (0.32-0.39) | 0.27 | (0.26-0.29) | 0.24 | (0.23-0.26) |
| Nerve sheath tumors | 0.27 | (0.24-0.30) | 0.21 | (0.18-0.24) | 0.26 | (0.22-0.29) | 0.35 | (0.32-0.39) | 0.27 | (0.26-0.29) | 0.24 | (0.23-0.26) |
| Other tumors of cranial and spinal nerves | – | – | – | – | – | – | – | – | – | – | – | – |
| Tumors of Meninges | 0.14 | (0.12-0.16) | 0.10 | (0.08-0.12) | 0.21 | (0.18-0.24) | 0.39 | (0.36-0.43) | 0.21 | (0.20-0.23) | 0.15 | (0.14-0.17) |
| Meningioma | 0.07 | (0.05-0.09) | 0.06 | (0.05-0.08) | 0.14 | (0.12-0.17) | 0.26 | (0.23-0.30) | 0.14 | (0.12-0.15) | 0.09 | (0.08-0.10) |
| Mesenchymal tumors | 0.06 | (0.04-0.07) | 0.03 | (0.02-0.04) | 0.03 | (0.02-0.04) | 0.03 | (0.02-0.05) | 0.04 | (0.03-0.04) | 0.04 | (0.03-0.05) |
| Primary melanocytic lesions | – | – | – | – | – | – | – | – | 0.01 | (0.00-0.01) | – | – |
| Other neoplasms related to the meninges | – | – | – | – | 0.03 | (0.02-0.05) | 0.09 | (0.07-0.11) | 0.03 | (0.03-0.04) | 0.02 | (0.01-0.02) |
| Lymphomas and Hemopoietic Neoplasms | – | – | 0.02 | (0.01-0.03) | 0.02 | (0.01-0.03) | 0.03 | (0.02-0.05) | 0.02 | (0.02-0.03) | 0.02 | (0.01-0.02) |
| Lymphoma | – | – | – | – | – | – | 0.02 | (0.02-0.04) | 0.02 | (0.01-0.02) | 0.01 | (0.01-0.02) |
| Other hemopoietic neoplasms | – | – | – | – | – | – | – | – | 0.01 | (0.01-0.01) | 0.01 | (0.00-0.01) |
| Germ Cell Tumors and Cysts | 0.13 | (0.11-0.15) | 0.14 | (0.11-0.16) | 0.27 | (0.23-0.30) | 0.29 | (0.26-0.32) | 0.20 | (0.19-0.22) | 0.18 | (0.16-0.19) |
| Germ cell tumors, cysts and heterotopias | 0.13 | (0.11-0.15) | 0.14 | (0.11-0.16) | 0.27 | (0.23-0.30) | 0.29 | (0.26-0.32) | 0.20 | (0.19-0.22) | 0.18 | (0.16-0.19) |
| Tumors of Sellar Region | 0.17 | (0.15-0.20) | 0.37 | (0.33-0.41) | 0.61 | (0.57-0.67) | 1.46 | (1.39-1.53) | 0.66 | (0.63-0.68) | 0.39 | (0.37-0.41) |
| Tumors of the pituitary | 0.03 | (0.02-0.05) | 0.11 | (0.09-0.13) | 0.40 | (0.36-0.44) | 1.31 | (1.24-1.38) | 0.47 | (0.45-0.49) | 0.18 | (0.17-0.20) |
| Craniopharyngioma | 0.14 | (0.12-0.16) | 0.26 | (0.23-0.29) | 0.22 | (0.19-0.25) | 0.15 | (0.13-0.18) | 0.19 | (0.18-0.21) | 0.21 | (0.19-0.22) |
| Unclassified Tumors | 0.22 | (0.19-0.25) | 0.18 | (0.15-0.21) | 0.26 | (0.22-0.29) | 0.36 | (0.33-0.40) | 0.25 | (0.24-0.27) | 0.22 | (0.20-0.24) |
| Hemangioma | 0.05 | (0.04-0.06) | 0.04 | (0.03-0.05) | 0.08 | (0.06-0.09) | 0.13 | (0.11-0.15) | 0.07 | (0.06-0.08) | 0.05 | (0.05-0.06) |
| Neoplasm, unspecified | 0.17 | (0.15-0.20) | 0.14 | (0.12-0.17) | 0.18 | (0.15-0.21) | 0.23 | (0.20-0.26) | 0.18 | (0.17-0.19) | 0.16 | (0.15-0.18) |
| All other | – | – | – | – | – | – | – | – | – | – | – | – |
| Total§ | 5.43 | (5.29-5.58) | 4.70 | (4.56-4.84) | 4.79 | (4.65-4.93) | 5.63 | (5.49-5.77) | 5.13 | (5.06-5.20) | 4.97 | (4.89-5.05) |
† Rates are per 100,000 and are age-adjusted to the 2000 US standard population.
§ Refers to all brain tumors including histologies not presented in this table.
- Counts and rates are not presented when fewer than 16 cases were reported for the specific histology category. The suppressed cases are included in the counts and rates for totals.
Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; NPCR, CDC's National Program of Cancer Registries; SEER, NCI's Surveillance, Epidemiology and End Results program; CI, confidence interval; NOS, not otherwise specified.